-
R. E. MacLaren
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom
Vitreoretinal Service, Moorfields Eye Hospital, London, United Kingdom
-
P. K. Buch
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom
-
A. Georgiadis
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom
-
M. Tschernutter
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom
-
R. A. Pearson
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom
-
A. J. Smith
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom
-
R. R. Ali
Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom